France's nuclear safety authority contributing regulatory expertise to EU research on reactor aging, radiation protection, and severe accident management.
ASNR is France's nuclear safety and radiation protection authority, responsible for regulating nuclear installations, overseeing radiation protection standards, and providing independent technical expertise on nuclear risks. In EU research, they contribute regulatory knowledge and safety assessment methodology to projects addressing nuclear plant aging, severe accident management, seismic risk, and radiation exposure. Their participation ensures that research outcomes align with real-world safety requirements and regulatory frameworks governing Europe's nuclear fleet.
ACES addresses concrete degradation and liner corrosion in aging plants, INCEFA-SCALE focuses on environmental assisted fatigue, and METIS covers seismic risk assessment for nuclear structures.
RadoNorm — their largest funded project (EUR 250K) — covers exposure assessment, dosimetry, health effects, and societal aspects of radiation protection.
AMHYCO focuses on hydrogen/CO combustion risk management during severe accidents, including containment integrity and passive autocatalytic recombiners.
SITEX-II built a sustainable network for independent technical expertise on radioactive waste disposal safety cases.
NECTAR explores neutron capture therapy for Alzheimer's disease — an unusual crossover applying nuclear physics expertise to neurodegenerative disease treatment.
ASNR's early H2020 involvement (2015) focused on radioactive waste governance and independent safety expertise networks (SITEX-II). From 2020 onward, their portfolio shifted decisively toward nuclear plant lifetime extension challenges — structural aging of concrete and steel, environmental fatigue, seismic resilience, and severe accident hydrogen management. This reflects the broader European reality of aging nuclear fleets requiring extended safe operation, and ASNR's need to build the scientific evidence base for regulatory decisions on plant life extensions.
ASNR is building deep expertise in long-term operation safety of aging nuclear infrastructure, positioning them as an essential regulatory voice in any European project addressing nuclear lifetime extension or decommissioning.
ASNR participates exclusively as a consortium partner, never as coordinator — consistent with their role as a regulatory body that contributes oversight expertise rather than driving research agendas. They operate in large consortia (120 unique partners across 7 projects), bringing the regulator's perspective to multinational research teams. Their relatively modest funding shares suggest they serve as expert advisors and validators rather than performing heavy experimental work, making them a low-overhead but high-credibility partner.
ASNR has collaborated with 120 unique partners across 29 countries, reflecting the pan-European nature of nuclear safety regulation. Their network spans the full ecosystem of nuclear research — technical safety organizations, national laboratories, universities, and industry operators across essentially all EU nuclear-capable nations.
ASNR brings something no university or private company can: the perspective of the national nuclear regulator. Their participation in a research project signals regulatory relevance and ensures findings will be grounded in actual safety requirements. For consortium builders, having the French nuclear authority on board adds credibility with evaluators and ensures research outputs are designed with regulatory acceptance in mind — critical for any project aiming to influence nuclear safety standards or plant operation decisions.
